comparemela.com

Latest Breaking News On - Earnings history for galmed pharmaceuticals - Page 1 : comparemela.com

Galmed Pharmaceuticals (NASDAQ:GLMD) Posts Earnings Results, Beats Estimates By $0 41 EPS

Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) issued its earnings results on Thursday. The biopharmaceutical company reported ($1.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.50) by $0.41, Zacks reports. Galmed Pharmaceuticals Price Performance Shares of GLMD traded up $0.11 during mid-day trading on Friday, reaching $4.74. The company had a trading […]

United kingdomEarnings history for galmed pharmaceuticalsGalmed pharmaceuticalsNews ratings for galmed pharmaceuticals dailyCambridge investment research advisors incMillennium managementHedge funds weigh in on galmed pharmaceuticalsGalmed pharmaceuticals ltdRaymond james financial services advisors incGalmed pharmaceuticals price performanceGet ratingInvestment research advisorsJames financial services advisorsGalmed pharmaceuticals daily

Galmed Pharmaceuticals (NASDAQ:GLMD) Issues Earnings Results, Beats Estimates By $0 41 EPS

Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) released its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.09) earnings per share for the quarter, topping the consensus estimate of ($1.50) by $0.41, Zacks reports. Galmed Pharmaceuticals Trading Up 2.4 % Shares of NASDAQ:GLMD traded up $0.11 during midday trading on Friday, hitting $4.74. 4,961 shares […]

United kingdomEarnings history for galmed pharmaceuticalsNews ratings for galmed pharmaceuticals dailyCambridge investment research advisors incGalmed pharmaceuticalsMillennium managementHedge funds weigh in on galmed pharmaceuticalsGalmed pharmaceuticals tradingGalmed pharmaceuticals ltdRaymond james financial services advisors incGet ratingInvestment research advisorsRaymond james financial services advisorsJames financial services advisorsGalmed pharmaceuticals daily

Brian L Matthews Buys 260 Shares of Perficient, Inc (NASDAQ:PRFT) Stock

Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.09) earnings per share for the quarter, topping the consensus estimate of ($1.50) by $0.41, Zacks reports. Galmed Pharmaceuticals Price Performance Shares of NASDAQ:GLMD traded up $0.11 on Friday, hitting $4.74. The company’s stock had a trading volume […]

United kingdomGalmed pharmaceuticalsCambridge investment research advisors incEarnings history for galmed pharmaceuticalsHedge funds weigh in on galmed pharmaceuticalsMillennium managementGalmed pharmaceuticals ltdRaymond james financial services advisors incGalmed pharmaceuticals price performanceNews ratings for galmed pharmaceuticals dailyGalmed pharmaceuticals company profileGet ratingInvestment research advisorsJames financial services advisorsGalmed pharmaceuticals daily

Galmed Pharmaceuticals (NASDAQ:GLMD) Posts Earnings Results, Beats Estimates By $0 41 EPS

Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) issued its earnings results on Thursday. The biopharmaceutical company reported ($1.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.50) by $0.41, Zacks reports. Galmed Pharmaceuticals Price Performance Shares of GLMD traded up $0.11 during mid-day trading on Friday, reaching $4.74. The company had a trading […]

United kingdomMillennium managementCambridge investment research advisors incHedge funds weigh in on galmed pharmaceuticalsNews ratings for galmed pharmaceuticals dailyGalmed pharmaceuticalsEarnings history for galmed pharmaceuticalsGalmed pharmaceuticals price performanceRaymond james financial services advisors incGalmed pharmaceuticals ltdGet ratingInvestment research advisorsJames financial services advisorsGalmed pharmaceuticals daily

vimarsana © 2020. All Rights Reserved.